| __timestamp | Galapagos NV | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 13774000 |
| Thursday, January 1, 2015 | 20309000 | 22479000 |
| Friday, January 1, 2016 | 16945000 | 27388000 |
| Sunday, January 1, 2017 | 20559000 | 35610000 |
| Monday, January 1, 2018 | 29641000 | 49007000 |
| Tuesday, January 1, 2019 | 88258000 | 61139000 |
| Wednesday, January 1, 2020 | 162170000 | 68836000 |
| Friday, January 1, 2021 | 167218000 | 97592000 |
| Saturday, January 1, 2022 | 239528000 | 106903000 |
| Sunday, January 1, 2023 | 94252000 | 120998000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Vericel Corporation and Galapagos NV have demonstrated contrasting trends in their SG&A expenditures. From 2014 to 2023, Galapagos NV saw a staggering increase of over 900% in SG&A expenses, peaking in 2022. In contrast, Vericel Corporation's expenses grew by approximately 780%, with a notable peak in 2023.
While both companies have shown significant growth, Galapagos NV's expenses surged dramatically in 2020, reflecting strategic investments or expansions. Vericel Corporation, however, maintained a steadier growth trajectory, suggesting a more controlled approach. These trends highlight the diverse strategies employed by biotech firms in managing operational costs, offering valuable insights for investors and industry analysts alike.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV